Sweden· SE-19720414000028
Nipaxon 2,5 mg/ml Oral suspension
A medicinal product containing noscapine, registered in Sweden by McNeil Sweden AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Noscapine
- Manufacturer
- McNeil Sweden AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19720414000028
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Noscapine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsEtos Hoestdrank Noscapine HCl 1 mg/ml, stroopHealthypharm B.V.
- GermanyCapval - DrageesInfectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
- BelgiumNosca-Mereprine 1 mg/mlCooper Consumer Health
- SwitzerlandGEM Hustenstiller mit Noscapinum 10 mg, PastillenTentan AG
- SpainTUSCALMAN 15 mg SUPOSITORIOS NIÑOSLaboratorio Farmaceutico S.I.T. - Specialita' Igienico Terapeutiche S.R.L.
- NorwayNoskapinOrifarm Healthcare A/S
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Belgium · Nosca-Méréprine
- Germany · Capval - Dragees, Capval-Saft
- Denmark · Noskapin Dak
- Spain · Tuscalman, Tuscalman Ninos
- Luxembourg · Nosca Méréprine, Nosca-Méréprine
- Netherlands · Hoestdrank Noscapine Hcl Etos, Hoestdrank Noscapine Hcl Htp
- Norway · Noskapin Orifarm Healthcare
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/98d0bfd3-dcaf-4bd6-9976-6c7d71fe32c4 GET /v1/drugs/98d0bfd3-dcaf-4bd6-9976-6c7d71fe32c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19720414000028",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19720414000028",
"product_doc_link": "https://docetp.mpa.se/LMF/Nipaxon%202.5%20mg%20per%20ml%20oral%20suspension%20SmPC_09001bee82ee717f.pdf"
}See everything about noscapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.